An Emory-invented antiviral treatment for COVID-19 has been authorized by British regulators, making molnupiravir the first antiviral pill approved for use against SARS-CoV-2. An emergency use application is also under consideration by the U.S. Food and Drug Administration.
Recent News Releases »
Faculty Opinion »
Opinion: COVID has made getting into a top U.S. college even more competitive and this new normal looks here to stay
Featured Expert »
Political scientist Andra Gillespie specializes in political mobilization and race and is the author of "The New Black Politician: Cory Booker, Newark and Post-Racial America."
How customized antibiotic combinations could defeat 'superbugs'
A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated. But tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible.
Emory in the News »
The Atlantic, Nov. 18
Savannah Morning News, Nov. 17
Atlanta Journal-Constitution, Nov. 17
New York Times, Nov. 17
- Emory Healthcare CEO Jonathan Lewin in a joint CNN column with Delta CEO Ed Bastian